By O’Shaughnessy’s News Service
Cannabidiol (CBD) is well on its way to becoming a household word. Increasing numbers of medical marijuana users know that the non-psychoactive cannabinoid dominant in hemp strains has important medical effects. CBD-rich plants have been crossed with one another and new strains of interest have been identified by labs. And, most significantly, extracts with measurable doses of THC and CBD are available.
Several offspring of the “Cannatonic” seeds originally provided to Project CBD by European allies were found to have a CBD-to-THC ratio slightly greater than 20-to-1. Similiar CBD:THC ratios have turned up in plants identified by the growers as “AC/DC” and “Oracle.”
Clones from these plants with 20 times more CBD than THC are being grown out in large quantities to meet the increasing demand for CBD-rich products by medical users.
“Project CBD played a big role in carrying the message,” says director Martin A. Lee. “What we could not achieve was a balance of supply and demand…”
Read the Project CBD Update in the Winter/Spring 2013 O’Shaughnessy’s
